Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 494Lymphoma 52Recurrence 49Neoplasms, Plasma Cell 49Immunoglobulin Light-chain Amyloidosis 43Neoplasms 35Lymphoma, Non-Hodgkin 35Leukemia 34Hematologic Neoplasms 32Myelodysplastic Syndromes 28Smoldering Multiple Myeloma 27Leukemia, Myeloid, Acute 26Leukemia, Plasma Cell 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Monoclonal Gammopathy of Undetermined Significance 18Hodgkin Disease 18Leukemia, Lymphocytic, Chronic, B-Cell 17Amyloidosis 17Lymphoma, B-Cell 15Breast Neoplasms 14Ovarian Neoplasms 12Paraproteinemias 11Myeloproliferative Disorders 10Colorectal Neoplasms 10Primary Myelofibrosis 9Melanoma 9Lymphoma, Follicular 9Infections 9Prostatic Neoplasms 8Lymphoproliferative Disorders 8

Interventions

Hizentra 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Common Variable Immunodeficiency × Plasma cell × Clear all
NCT06976476 2026-03-11

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
100 enrolled
Plasma cell

Agammaglobulinemia, Multiple Myeloma, Common Variable Immunodeficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡